Delivery Order SPE2DB22D3301-SPE2DB24FZ4HT

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $11,952.94 firm-fixed-price contract is for the supply of JANUMET XR 50-1,000 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of pharmaceutical and medical supplies to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of JANUMET XR 100-1,000 mg tablets in 90-count packages. The award has a ceiling value of $1,660.81 and a completion date of August 20, 2024. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen, one of the largest pharmaceutical distributors in the U.S., will leverage its extensive supply chain...
This is a $6,157.44 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. The contract is for the supply of JANUMET XR 50-1,000 mg tablet (60s) and does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded multiple indefinite-delivery contracts by DLA and other federal agencies to provide a wide range of essential medical commodities, including prescription drugs, vaccines, and...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Janumet XR 50-1,000 mg tablets. The contract has a ceiling value of $10,498.84 and an ultimate completion date of November 14, 2023. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $2,045.52, is for the delivery of Janumet XR 50-1,000 mg tablets. It is a firm fixed-price contract with an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of JANUMET XR 50-1,000 MG tablets. The order, valued at $12,583.70, is a firm-fixed-price contract with an ultimate completion date of August 30, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, allowing them to efficiently provide a wide range of pharmaceutical and medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of JANUMET XR 100-1,000 mg tablets. The contract has a ceiling value of $2,905.36 and an ultimate completion date of September 12, 2024. The contract is a firm-fixed-price delivery order and is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, will provide these prescription medications to support military treatment...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $1,131.23 firm fixed-price contract is for the supply of JANUMET XR 50-1,000 MG tablets. This contract is not set aside for any specific socioeconomic category. The contract has an ultimate completion date of January 17, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,936.63, is for the supply of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of January 23, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 that...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,069.56, is for the supply of Janumet XR 50-1,000 mg tablet prescription medication. The contract is a firm fixed-price delivery order with an ultimate completion date of May 17, 2023. This delivery order is placed under AmerisourceBergen's larger Indefinite...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ4HT
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Janumet XR 50-1,000 mg tablets. The $12,441.53 firm fixed-price contract has an ultimate completion date of September 12, 2024. AmerisourceBergen, a major pharmaceutical distributor, is providing these prescription medications under a larger DLA Troop Support Medical Indefinite Delivery Contract valued up to $999,999,999 through December 2025. This contract allows DLA to efficiently procure a wide range of medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 12/11/24, 9:17 AM